This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Compagnie Gervais Danone, Bifinove. Active years: 2008-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2016
Title: The Innovations of Jean-Pierre Blareau
Introduction
Jean-Pierre Blareau is a notable inventor based in Steenvoorde, France. He has made significant contributions to the field of biotechnology, particularly in the development of macromolecular complexes with medical applications. With a total of four patents to his name, Blareau's work has the potential to impact the treatment of various inflammatory conditions.
Latest Patents
Among his latest patents, Blareau has developed a macromolecular complex of bacterial origin aimed at preventing and treating inflammatory rheumatism. This complex is produced by bacteria belonging to a specific strain deposited under number CNCM I-3994 with the National Collection of Microorganism Cultures. The complex consists of chains that combine a lipoprotein and an oligosaccharide. Additionally, he has created an immunomodulatory product obtained from a bifidobacterium culture, which can be used as a medicament or food ingredient, along with pharmaceutical or food compositions containing this product.
Career Highlights
Throughout his career, Jean-Pierre Blareau has worked with prominent companies such as Compagnie Gervais Danone and Bifinove. His experience in these organizations has allowed him to refine his expertise in biotechnology and innovation.
Collaborations
Blareau has collaborated with notable individuals in his field, including Marie-Bénédicte Romond and Charles Romond. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Jean-Pierre Blareau's innovative work in biotechnology, particularly in the area of macromolecular complexes, showcases his commitment to advancing medical science. His patents reflect a dedication to improving health outcomes through scientific research and collaboration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
